Program overview
Context
Indication: Pancreatic Neoplasms
Mechanism: Unknown
Modality: Unknown
Sponsor: Celgene
Operational Burden Signal
nab-Paclitaxel
nab-Paclitaxel is flagged as operational burden signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 1/5
Recruitment burden: 3/5
Results availability: 0/5
Program risk: 2/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT02301143 | https://clinicaltrials.gov/study/NCT02033993 | https://clinicaltrials.gov/study/NCT07340398
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT02301143 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | None |
| NCT02033993 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | strict_eligibility_signal |
| NCT07340398 | Low Signal (RECRUITING) | None | Low Signal | large_enrollment_target_signal | few_sites_large_trial_signal | rare_population_signal |